The study assesses the management of antimicrobial resistance (AMR) in 193 countries to inform the 2026 update of the Global Action Plan.[1] Countries with strong multisectoral management and early adoption of surveillance have achieved long-term improvements in AMR reduction.[1] AMR surveillance management in low- and middle-income countries has been strengthened over the five years to 2024, and is approaching that of high-income countries.[1] Southeast Asian countries have shown relatively strong improvements, a notable exception to the limited global progress.[1] Of the 15 indicators, clear progress was reported in only four: two on strengthening AMR surveillance in human and animal health and two on regulatory frameworks in animal health.[1] More than 170 countries have developed multisectoral national action plans on AMR.[3] In 2025, 104 countries reported data on antimicrobial resistance and use to the GLASS system.[3] The study highlights the effectiveness of initiatives like the Fleming Fund in strengthening surveillance in human and animal health.[1]